When Joseph Wayne Singleton, a 45‑year‑old guitarist and vocalist from Opelousas, Louisiana, asked his doctor for a more thorough physical at his wife’s urging, the exam uncovered a life‑saving diagnosis. Although he was well below the age most guidelines recommend for routine prostate‑specific antigen (PSA) testing, his physician ordered the blood test anyway.
Unexpected results lead to early treatment
Singleton’s PSA levels returned “through the roof,” prompting a biopsy that confirmed prostate cancer. “It was totally unexpected – no symptoms,” he told Fox News Digital. The cancer was caught at an early stage, allowing him to undergo a prostatectomy at the UT MD Anderson Cancer Center in Houston, Texas.
He describes his recovery as “miraculous.” Within weeks he was back on airplanes, touring with his band across the country. “By the grace of God, I’m here now,” Singleton said, noting that the experience forced him to reflect on his purpose and health.
Advocacy for earlier screening
Now, Singleton uses his platform as a traveling musician to encourage men, especially those under 50, to discuss prostate health with their doctors. “I’m still here after all those years, and there was definitely a purpose behind everything that happened,” he said. He hopes his story will motivate others to seek testing before symptoms appear.
Current medical guidelines do not universally recommend routine PSA screening for men under 45 who have no symptoms or known risk factors. The American Cancer Society’s senior vice president of cancer screening, Robert Smith, Ph.D., explained that clinicians should discuss the benefits, limitations, and potential harms of screening with each patient rather than issuing a blanket recommendation.
Guidelines vary: some suggest starting at age 45 for average‑risk men, while others advise beginning at 50 or 55. For higher‑risk groups—such as Black men or those with a family history—screening may start as early as 40‑45. Recommendations also differ on how often testing should occur, ranging from annually to every two to four years, and when to stop, typically between ages 69 and 75 or when life expectancy falls below ten years.
Balancing benefits and risks
Experts stress that screening can reduce deaths from advanced prostate cancer, but it also carries risks of overdiagnosis, overtreatment, and side effects like urinary incontinence and erectile dysfunction. New strategies aim to mitigate these harms while preserving the life‑saving potential of early detection.
Smith added that maintaining a healthy lifestyle—balanced diet, regular exercise, avoiding tobacco, limiting alcohol, and staying sexually active—may lower overall cancer risk, though no method can guarantee prevention.
Local relevance
Singleton’s story resonates with Louisiana’s own health community, where prostate cancer remains a leading cause of cancer death among men. Local physicians and advocacy groups can use his experience to foster open conversations about screening, especially in underserved areas where access to specialty care may be limited.
“If I could help prevent somebody else from going through what I might have gone through, that’s the main goal,” Singleton said. His message underscores the importance of personal responsibility, faith, and family support in navigating health challenges.
Original reporting: Fox News (HLL/CB) — read the source article.
